X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs MYLAN (US) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   MYLAN
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
MYLAN
Dec-14
STERLING BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs113,805-   
Low Rs32,682-   
Sales per share (Unadj.) Rs26.81,302.8-  
Earnings per share (Unadj.) Rs-15.0156.9-  
Cash flow per share (Unadj.) Rs-5.5252.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9647.6-  
Shares outstanding (eoy) m267.87378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.32.5 10.4%   
Avg P/E ratio x-0.520.7 -2.2%  
P/CF ratio (eoy) x-1.312.8 -9.9%  
Price / Book Value ratio x0.15.0 2.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8621,227,273 0.2%   
No. of employees `0001.425.0 5.4%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.319,716.9 26.9%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.02,375.2 -124.6%   
INCOME DATA
Net Sales Rs m7,181492,922 1.5%  
Other income Rs m43-2,873 -1.5%   
Total revenues Rs m7,223490,049 1.5%   
Gross profit Rs m947122,592 0.8%  
Depreciation Rs m2,54336,203 7.0%   
Interest Rs m4,37721,262 20.6%   
Profit before tax Rs m-5,93162,254 -9.5%   
Minority Interest Rs m0-255 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9242,618 -73.5%   
Profit after tax Rs m-4,00759,381 -6.7%  
Gross profit margin %13.224.9 53.0%  
Effective tax rate %32.44.2 771.6%   
Net profit margin %-55.812.0 -463.2%  
BALANCE SHEET DATA
Current assets Rs m14,335433,344 3.3%   
Current liabilities Rs m49,809338,788 14.7%   
Net working cap to sales %-494.019.2 -2,575.4%  
Current ratio x0.31.3 22.5%  
Inventory Days Days40378 516.7%  
Debtors Days Days171107 159.1%  
Net fixed assets Rs m55,432114,036 48.6%   
Share capital Rs m26817,431 1.5%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,701245,031 6.0%   
Long term debt Rs m9,478366,052 2.6%   
Total assets Rs m73,988986,961 7.5%  
Interest coverage x-0.43.9 -9.0%   
Debt to equity ratio x0.61.5 43.2%  
Sales to assets ratio x0.10.5 19.4%   
Return on assets %0.58.2 6.1%  
Return on equity %-27.324.2 -112.5%  
Return on capital %-6.413.6 -47.2%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,71964,795 2.7%  
From Investments Rs m-3,148-51,099 6.2%  
From Financial Activity Rs m1,426-17,073 -8.4%  
Net Cashflow Rs m-3-3,378 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare STERLING BIOTECH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: J.B.CHEMICALS  ELDER PHARMA  AUROBINDO PHARMA  GSK PHARMA  NOVARTIS  



Today's Market

Sensex & Nifty Open at Record Highs; Banking & PSU Stocks Rally(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.46% while the Hang Seng is up 0.28%. The Shanghai Composite is trading up by 0.43%.

Related Views On News

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Jan 18, 2018 11:43 AM

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS